BIIB Jan 2025 285.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:44PM EDT. Market open.
Loading interactive chart…
- Zacks
Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
Biogen Is Suffering From Doubts About the Future
A closer look at one of the leaders in the global multiple sclerosis therapeutics market
- Investor's Business Daily
Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision?
The FDA will now hold an advisory committee meeting to discuss Eli Lilly's Alzheimer's drug, donanemab. Is Eli Lilly stock a buy or a sell?
© 2024 Yahoo. All rights reserved.